Prevention and Control of Contamination in Pharmaceutical – PST04102 Disease Control and Prevention

NTA Level 4 • Semester 1 • PST04102

Prevention and Control of Contamination in Pharmaceutical

Disease Control and Prevention • Source Session/Topic 40
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 40: Prevention and Control of Contamination in Pharmaceutical

Settings

Total Session Time: 120 minutes + 2 hours Assignment

Prerequisites

• None

Learning Tasks

By the end of this session students are expected to be able to:

• Explain Sources of Contamination in Pharmaceutical Settings
• Explain The Consequences of Contamination on Pharmaceutical Products
• Describe Measures for Preventing and Controlling Contamination in

Pharmaceutical Settings

Resources Needed

• Flip charts, marker pens, and masking tape
• Black/white board and chalk/whiteboard markers
• Computer and LCD

SESSION OVERVIEW

|Step |Time |Activity/ |Content |

| | |Method | |

|1 |05 minutes |Presentation |Introduction, Learning Tasks |

|2 |20 minutes |Presentation |Sources of Contamination in |

| | |Brainstorm |Pharmaceutical Settings |

|3 |20 minutes |Presentation |Consequences of Contamination on |

| | |Buzzing |Pharmaceutical Products |

|4 |50 minutes |Presentation |Measures for Preventing and |

| | |Small group |Controlling Contamination in |

| | |discussion |Pharmaceutical Settings |

|5 |05 minutes |Presentation |Key Points |

|6 |10 minutes |Presentation |Evaluation |

|7 |10 minutes |Presentation |Assignment |

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing

STEP 2: Sources of Contamination in Pharmaceutical Settings (20 minutes)

|Activity: Brainstorming (10 minutes) |

| |

|Ask students to brainstorm on the following question: |

| |

|What are sources of contamination in pharmaceutical setting? |

| |

|ALLOW few students to respond |

| |

|WRITE their responses on the flip chart/ board |

| |

|CLARIFY and SUMMARISE by using the content below |

Microbiological contamination

Refers to non- intended or accidental introduction of infectious material

like bacteria, yeast, mould, fungi, virus, prions, protozoa or their toxins

and by-products

Sources of contamination in pharmaceutical settings

In manufacture/ compounding

• Regardless of whether manufacture takes place in industry or on a smaller

scale in the hospital pharmacy, the microbiological quality of the

finished product will be determined by:

o Formulation components used

o Environment in which they are manufactured

o Manufacturing process itself.

• Quality must be built into the product at all stages of the process and

not inspected at the end of manufacture or compounding. The following are

sources of contamination:

o Raw materials: particularly water and ingredients

o Processing equipment

o Cleaning equipment: Premises/environment

o Staff

o Packaging

In use

• Pharmaceutical manufacturers may argue that their responsibility ends

with the supply of a well- preserved product of high microbiological

standard in a suitable pack and that the subsequent use, or abuse, of

the product is of little concern to them.

• Products such as multi-dose may acquire contamination on their

continued use or if subjected in a contaminated state, particularly in

hospitals where it could result in the spread of cross – infection.

• Human sources:

o During normal usage, patients may contaminate their medicine with

their own microbial flora; subsequent use of such products may or may

not result in self – infection.

o Topical products are considered to be most at risk, as the product

will probably be applied by hand, thus introducing contaminants from

the resident skin flora of staphylococci,

o Micrococcus species and diphtheroids but also perhaps transient

contaminants, such as pseudomonas or coliforms, which would normally

be removed with effective hand- washing.

o A further potential source of contamination in hospitals is the

nursing staff responsible for medicament administration.

• Environmental sources:

o Small numbers of airborne contaminants may settle in products left

open to the atmosphere.

• Equipment sources:

o Patients and nursing staff may use a range of applicators (pads,

sponges, brushes and spatulas) during medicament administration,

particularly for topical products

o If reused, these easily become contaminated and may be responsible for

perpetuating contamination between fresh stocks of product, as has

indeed been shown in studies of cosmetic products.

STEP 3: Consequences of Contamination on Pharmaceutical Products (20

minutes)

|Activity: Buzzing (5 minutes) |

| |

|ASK students to pair up and buzz on the following question for 2 |

|minutes |

| |

|What are the consequences of contamination on pharmaceutical products? |

| |

|ALLOW few pairs to respond and let other pairs to add on points not |

|mentioned |

| |

|WRITE their response on the flip chart/board |

| |

|CLARIFY and SUMMARIZE by using the content below |

• Initiating infections

o Cross-contamination of medicines contributes to most of the

nosocomial infections occurring in hospitals

o It also accounts for most of the postsurgical infections and deaths

occurring in hospitals.

o Cross-contaminated medicines weaken the relationship between patients

and healthcare givers.

o This occurs mostly in the event of drug resistance and treatment

failure, but also infections due to contaminated medicines make

patients lose trust in their health care givers.

• Medicines spoilage

o This occurs by microorganisms chemically decomposing the active

ingredient or the excipients. This may lead to:

▪ The product being under- strength,
▪ Physically or chemically unstable, or possibly
▪ Contaminated with toxic materials.
• Financial loss

o Contaminated products have financial implications in terms of:

▪ additional treatment costs
▪ product recalls
▪ possible litigation/ legal action
▪ damage to the reputation of the manufacturer or compounder

STEP 4: Measures for Preventing and Controlling Contamination in

Pharmaceutical Settings (50 minutes)

|Activity: Small Group Discussion (10 minutes) |

| |

|DIVIDE students into small manageable groups |

| |

|ASK students to discuss on the following question |

|What are the measures for preventing and controlling contamination in |

|pharmaceutical settings? |

| |

|ALLOW students to discuss for 10 minutes |

| |

|ALLOW few groups to present and the rest to add points not mentioned |

| |

|CLARIFY and SUMMARIZE by using the contents below |

• Raw materials, particularly water and those ingredients of natural

origin, must be of a high microbiological standard.

• Water for pharmaceutical manufacture requires some further treatment,

usually by distillation, reverse osmosis or deionization

• Processing and compounding equipment should be subjected to planned

preventive maintenance and should be properly cleaned after use to

prevent cross – contamination between batches

• Cleaning equipment should be appropriate for the task in hand and should

be thoroughly cleaned and properly maintained.

o These are responsible for distributing organisms around the pharmacy

area.

o For example mops, buckets, cleaning cloths and scrubbing machines if

stored wet they provide a convenient niche for microbial growth.

• Manufacture should take place in suitable premises, supplied with

filtered air, for which the environmental requirements vary according

to the type of product being made.

• Free – living opportunist pathogens, such as pseudomonas aeruginosa,

can normally be found in wet sites, such as drains, sinks and taps.

o This may be minimized by observing good manufacturing practices (GMP),

by installing heating traps in sink U – bends, thus destroying one of

the main reservoirs of contaminants

• Patients and nurses use a range of applicators (pads, sponges,

brushes, spatulas and spoons) during medicament administration,

particularly for topical and oral products.

• These should be made as disposable so as to minimise contamination.
• In busy wards:

o Hand – washing between attending to patients may be overlooked and

o Contaminants may subsequently be transferred to medicaments during

administration

o Emphasize use of non – touch techniques for medicament administration

• Staff involved in manufacture or compounding should not only have good

health but also a sound knowledge of the importance of personal and

production hygiene.

• They should dress appropriately and use protective gears such as boots,

coats, caps, gloves and masks in controlling contamination

• The end – products requires suitable packaging which will protect it from

contamination during its shelf- life and is itself free from

contamination.

• Sacking, cardboard, card liners, corks and paper are unsuitable for

packaging pharmaceuticals, as they are heavily contaminated.

o These have now been replaced by non -biodegradable plastic materials.

o Re-use of packaging materials should be discouraged.

o Effective control method includes the supply of products in individual

patient’s packs.

STEP 5: Key Points (5 minutes)

• Contamination of pharmaceutical products may occur during

manufacturing/compounding and use

• Consequences of medicine contamination include; initiation of infections,

products spoilage and financial loss

• It is important to use different preventive measures for controlling

contamination in pharmaceutical settings in order to minimize the risks

of contamination.

STEP 6: Evaluation (10 minutes)

• What are the sources of contamination in pharmaceutical settings?
• What are the consequences of contamination on pharmaceutical products?
• What are the measures for preventing and controlling contamination in

pharmaceutical settings?

STEP 7: Assignment (10 minutes)

|Activity: Take Home Assignment (10 minutes) |

| |

|DIVIDE students in groups or individuals |

| |

|ASK the students to work on the following Assignment |

|Visit a hospital pharmacy department, basing on its design/set up; |

|write a presentation on factors responsible for contamination of |

|pharmaceutical products and give suggestions on what should be done to |

|avoid the consequences of contamination. |

| |

|ALLOCATE time for students to do the assignments and submit |

| |

|REFER students to recommended references |

References

Denyer, P. D, Hodges, N. Gorman, S. P. & Gilmore, B. F. (2011). Hugo &

Russell’sPharmaceutical Microbiology. (8thed.). West Sussex:Blackwell

Publishing Ltd,

Gabriel J (2008). Infusion therapy: Prevention and management of

complications. Nurs Stand.; 22(32): 41-48

Senya, S., Mwasha, C.Y.S, Muyinga, A.M, Amir, R.I, & Mauga, E.A.S.K, (2011)

Tanzania Pharmaceutical Handbook. (2nded.). Dar es Salaam: ARU Printing

Unit

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top